
Differences in Early Immunosuppressive Therapy Among Liver Retransplantation Recipients in a National Cohort
Author(s) -
Alyssa Mezochow,
Peter Abt,
Therese Bittermann
Publication year - 2021
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000003417
Subject(s) - medicine , calcineurin , regimen , hazard ratio , proportional hazards model , cohort , immunosuppression , liver transplantation , retrospective cohort study , liver disease , surgery , transplantation , confidence interval
There is no unified consensus as to the preferred immunosuppression (IS) strategy following liver retransplantation (reLT).